Eli Lilly to offer early access to next-gen obesity drug to some patients - Reuters
Eli Lilly to offer early access to next-gen obesity drug to some patients Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSUF6THY1UW04aGlCR241STFzUE94MXlyMjZFSVNWaG9aYkRPVFVvdW5FRVZ3NHd3RXQzSjkybFhCWEhZZVpNTExxSDlwNDNRWW95SG0xcGVUVVozU09SMHR3RUR5b3Q2SFNYaTZvbzBWbV9fNTA4WjVOTGk1cUdhYkN2bl9rR19VcmpFV256VktIb243aHpZQ1RxNVR5ZldFNkpKUk9NNVFjb2Nmd1NxcFBDVzFnMURv?oc=5" target="_blank">Eli Lilly to offer early access to next-gen obesity drug to some patients</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Boots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PMHumana surges after topping 2027 Medicare star ratings - Reuters
Humana surges after topping 2027 Medicare star ratings Reuters
October 9, 2026 at 01:33 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMMost Medicare Advantage drug plan enrollees in high-quality plans, US government says - Reuters
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says Reuters
October 8, 2026 at 11:29 PMADHD and autism at risk of over-diagnosis, says government review
The review, which focuses on younger people, warned there was a risk society was moving from an era of under-diagnosis to over-diagnosis.
October 8, 2026 at 11:01 PM